Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02588131
Brief Title: A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)

First Submitted : October 26, 2015
First Submitted that Met QC Criteria : October 26, 2015
First Posted : October 27, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : October 26, 2015
Last Update Posted : October 27, 2015 (Estimate)